prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |review
Now, we have set out a series of investment priorities with that kind of strategy. Like most of the NIH, our major investment is in extramural research. We’re funding 200 applications for research training and research around the United States today, as well as a few growing internationally, and these fund a whole range of approaches: Phase I to Phase III, clinical studies, pre-clinical mechanistic and translational research, as well as research training.

…We have established an intramural laboratory and clinically based research program. … It’s emphasizing clinical and translational studies of CAM approaches to age-related stressors. The frailty, the dementia, the depression, the loss of bone mass that occurs with aging. And that intramural program, as all intramural programs here, creates a nidus for research training.